This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SNBP Sun BioPharma (SNBP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Sun BioPharma Stock (NASDAQ:SNBP) 30 days 90 days 365 days Advanced Chart Get Sun BioPharma alerts:Sign Up Key Stats Today's Range N/A50-Day Range$3.45▼$4.5052-Week Range N/AVolume49,422 shsAverage Volume26,926 shsMarket Capitalization$3.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota. Read More Receive SNBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sun BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address SNBP Stock News HeadlinesSun Pharma Q1 preview: High domestic, global specialty biz growth to boost revenueJuly 31 at 2:55 AM | msn.comIndia's Sun Pharma posts bigger adjusted profit on demand for rare disease drugsMay 23, 2025 | msn.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.August 2 at 2:00 AM | Brownstone Research (Ad)India's Sun Pharma posts quarterly profit rise on strong demand for rare disease drugsMay 22, 2025 | msn.comSun Pharma's Checkpoint Bid Seen As A Strategic Win By MacquarieMay 20, 2025 | msn.comIndia's Sun Pharma to acquire Checkpoint Therapeutics for $355 millionMarch 10, 2025 | msn.comSun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip ShanghviMarch 3, 2025 | msn.comSun Pharma share price plunges 5% after US ruling on Leqselvi launch - Here's what JPMorgan, UBS sayNovember 5, 2024 | msn.comSee More Headlines SNBP Stock Analysis - Frequently Asked Questions How were Sun BioPharma's earnings last quarter? Sun BioPharma, Inc. (NASDAQ:SNBP) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09. What other stocks do shareholders of Sun BioPharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sun BioPharma investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Heatwurx (PCSA), Akero Therapeutics (AKRO), Athabasca Oil (ATH), Black Iron (BKI) and Berry (BRY). Company Calendar Last Earnings11/12/2020Today8/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNBP CIKN/A Webwww.sunbiopharma.com Phone952-479-1196FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares9,649,000Free FloatN/AMarket Cap$3.96 million OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:SNBP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sun BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sun BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
